Marketsupdated today

Does the UK clear the AkzoNobel-Axalta merger without a Phase 2 probe?

Will the UK Competition and Markets Authority clear AkzoNobel's roughly $25 billion all-stock merger with Axalta Coating Systems at Phase 1, without referring it to an in-depth Phase 2 investigation, by its November 11, 2026 statutory deadline?

62% yes — CMA clears the merger at Phase 1

Leans toward UK clearance — the bulk of UK Phase 1 reviews clear without a Phase 2 referral, and the companies' parallel EU remedy offer (divesting Axalta's vehicle-refinish unit) suggests they're already moving to resolve the overlap regulators care most about

The case for clearance: the large majority of CMA Phase 1 merger reviews clear without a Phase 2 referral, the companies have already signaled willingness to offer remedies (the EU vehicle-refinish divestiture) that could be mirrored in the UK process, and shareholders on both sides have already approved the deal. The case for a referral: Capitol Forum's sourcing flags the combined group's probable dominance in powder coatings as a genuine structural concern, Bernstein's downgrade cites real execution and antitrust risk across jurisdictions for a deal this size, and the UK and EU reviews — while separate — tend to flag similar overlaps, so a tough EU remedy demand would be a bad sign for the UK process too.

Resolves Nov 11, 2026 · CMA's statutory Phase 1 decision deadline on whether to refer the AkzoNobel-Axalta coatings merger to a Phase 2 investigation

AkzoNobel and Axalta shareholders approved their all-stock merger of equals on Aug 5, 2026 (AkzoNobel holders to own about 55%, Axalta holders about 45% of the combined roughly $17B-revenue, $25B-enterprise-value company). The UK CMA opened its formal Phase 1 inquiry on Sept 16-17 after an earlier April-May comment period, with a Nov 11 statutory deadline to decide whether to refer the deal to Phase 2. The companies are simultaneously working the EU process on a parallel track: Reuters/PYMNTS reported Oct 8 that AkzoNobel and Axalta are offering to divest Axalta's vehicle-refinishing business to resolve the European Commission's remaining concern, after earlier worries about overlapping powder-coatings operations were resolved; the EU's own Oct 22 deadline is expected to be extended roughly two weeks once that formal remedy lands. Bernstein downgraded AkzoNobel to 'market perform' on deal-execution risk, and Capitol Forum has reported sourcing suggesting the EU could still demand structural remedies given the combined group's strength in powder coatings. The companies target closing in late 2026 or early 2027.

The CMA's Phase 1 decision is a discrete regulatory fork required by UK merger-control law: by the statutory deadline it either clears the deal (with or without accepted remedies) or refers it to a Phase 2 investigation that adds months of review and real deal-break risk — there is no third, partial outcome at this stage.

Researched Oct 13, 2026 · tracked since Oct 13, 2026

Build a position

market 62%you 62%no edge

You agree with the market.

Nothing here has positive expected value — the price already reflects this view. Move the slider to where you think the odds actually are.

Take a side

CMA clears the merger at Phase 1this is “yes”

The large majority of CMA Phase 1 reviews clear without a Phase 2 referral, the companies have already shown they'll offer remedies (the EU vehicle-refinish divestiture) to resolve regulators' core concerns, and both companies' shareholders have already approved the deal.

Long

AXTA Axalta Coating Systems Ltd.The US-listed merger target; a UK clearance removes one of several regulatory hurdles to closing and narrows the merger-arb spread, while a Phase 2 referral extends the timeline and raises break risk.

Long

AKZOY Akzo Nobel N.V.The other merging party, trading in the US as an ADR; same deal-completion logic as Axalta, sized smaller since Akzo is the larger 'acquirer' side of an all-stock merger of equals.

Long

MNA IQ Merger Arbitrage ETFA diversified merger-arbitrage fund; clearance of a prominent, large pending deal is a mild positive read-through for merger-arb sentiment broadly, since it reduces the perceived regulatory-risk overhang across the asset class.

Short

PPG PPG Industries, Inc.The largest direct US-listed coatings competitor; a Phase 2 referral that delays or weakens the AkzoNobel-Axalta combination reduces the competitive threat PPG faces, while a clean clearance strengthens a rival at PPG's expense.

Short

SHW The Sherwin-Williams CompanyAnother major US-listed coatings competitor; same competitive-dynamics logic as PPG applies, sized smaller given Sherwin-Williams' heavier weighting toward US retail/pro paint versus the more industrial AkzoNobel-Axalta overlap.

Short

RPM RPM International Inc.A smaller US-listed specialty-coatings competitor; a diluted version of the same competitive read-through as PPG and Sherwin-Williams given RPM's narrower overlap with the merging companies' core segments.

Worth knowing: The CMA can still accept remedies at Phase 1 without a full Phase 2 referral — a 'clearance' in this topic's binary sense could still come bundled with a forced divestiture, so don't read 'cleared' as 'no concessions required.'

CMA refers the merger to Phase 2

Capitol Forum's sourcing flags the combined group's probable powder-coatings dominance as a real structural concern, Bernstein's downgrade cites genuine cross-jurisdiction execution and antitrust risk, and a tough EU remedy demand on the same overlaps would be a bad omen for the UK review too.

Short

Long

Worth knowing: Referral rates at UK Phase 1 are low historically — betting on a referral is betting against a strong base rate, even where real overlaps like vehicle-refinish coatings exist.

5 sources, leaning both ways

mixedGOV.UK (CMA) — AkzoNobel / Axalta merger inquiry case pageChecked Oct 13: the CMA's own case page confirms the Phase 1 inquiry opened Sept 16-17 with a Nov 11 statutory deadline to decide on a Phase 2 referral — the primary-source timeline this topic resolves against.
mixedPainting & Coating Industry (PCI) — UK regulator opens Phase 1 review of AkzoNobel/Axalta mergerConfirms the Sept 16 formal notice, the Nov 11 deadline, that shareholders of both companies approved the deal Aug 5, and that the companies target a late-2026/early-2027 close subject to regulatory approvals.
mixedBusiness News Today — Will competition scrutiny change the colour of AkzoNobel and Axalta's $25bn merger?Lays out the CMA's review framework (overlap, bundling, distribution-network leverage) as 'questions for evidence, not established findings,' and notes both stocks dipped modestly (AkzoNobel -0.74%, Axalta -1.29%) on the UK review news, evidence of some investor caution.
yesPYMNTS — AkzoNobel, Axalta nearing EU clearance with vehicle-refinishing divestiture offerOct 8: reports the companies are offering to divest Axalta's vehicle-refinishing business to resolve the EU's remaining competition concern, with earlier powder-coatings worries already resolved — a concrete sign the deal is moving toward conditional clearance rather than a prolonged standoff.
noTradingView (Reuters) — Bernstein downgrades AkzoNobel on Axalta merger worriesDocuments Bernstein's downgrade of AkzoNobel to 'market perform' citing execution risk, the possibility of the deal being altered through shareholder pressure or antitrust review, and skepticism that the combined group's growth outpaces PPG's.